Urinary bladder cancer can begin with symptoms that look like a UTI, prostate problem or simply ageing. Here are the early ...

A new study has found that the use of a specific at-home urine test could detect bladder cancer with accuracy. Here are its ...

Remission rates observed in a Phase 2 trial fell short of Wall Street's expectations, though some analysts believe the ...

Despite falling short of analyst expectations, Tyra Biosciences is taking its cancer drug to registrational development for ...

A new combination of cancer medications appears to extend overall survival in patients with advanced bladder cancer more than the chemotherapies currently used as the standard of care. The research, ...

A study co-author told Newsweek the test is already helping some National Health Service sites clear cystoscopy backlogs.

Squamous cell carcinoma of the bladder is rare, accounting for 2% to 5% of bladder cancers in the U.S., and is linked to chronic bladder irritation. Diagnosis involves cystoscopy, biopsy, and imaging ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...

In this study, researchers aimed to evaluate bladder cancer trial availability across US counties and its associations with bladder cancer incidence and mortality.

Tyra Biosciences has reported initial phase 2 data on dabogratinib in bladd | Tyra Biosciences has reported initial phase 2 ...